Abstract
After several decades of research, recent successful phase III controlled clinical trials have renewed enthusiasm for vaccine treatment of cancer. This perspective on the report by Berta and colleagues in this issue of the journal (beginning on page 994) discusses the potential prevention of oral cancer through vaccine strategies and, in the broader context, ideal characteristics of tumor antigens as candidates for vaccines for both treating and preventing cancer, potential primary and secondary prevention settings for vaccines, desirable types of immune effectors induced by vaccines, and safety.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 954-956 |
| Number of pages | 3 |
| Journal | Cancer Prevention Research |
| Volume | 4 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2011 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Cancer vaccines: Moving toward prevention?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS